Mastalgia: Tailoring treatment to type of breast pain

Postgraduate Medicine

Volumn 102, Issue 5, 1997, Pages 183-198

  Steinbrunn, Barbara Schmidt ^a   Zera, Richard Thomas ^a   Rodriguez, Jorge Luis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE MESILATE; DANAZOL; ESSENTIAL FATTY ACID; GESTRINONE; GONADORELIN DERIVATIVE; LIDOCAINE; METHYLPREDNISOLONE ACETATE; NAFARELIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRIMROSE OIL; PROLACTIN; SATURATED FATTY ACID; TAMOXIFEN CITRATE;

BREAST CANCER; CANCER RISK; CLINICAL TRIAL; DIETARY INTAKE; DISEASE CLASSIFICATION; DOSE RESPONSE; HEADACHE; HOT FLUSH; HUMAN; IRRITABILITY; LEG CRAMP; LIBIDO; MASTALGIA; MENSTRUATION DISORDER; NAUSEA; RELAPSE; REVIEW; SIDE EFFECT; TIETZE SYNDROME; VERTIGO; WEIGHT GAIN;

EID: 0030727485     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.11.369     Document Type: Review

References (34)

1. Cooper AP. Illustrations of the diseases of the breast. Pt 1. London: Longman, Rees, Orme, Brown, & Green, 1829
2. Atkins HJB. Chronic mastitis. Lancet 1938;1(Mar 26):707-12
3. Preece PE, Mansel RE, Hughes LE. Mastalgia: psychoneurosis or organic disease? Br Med J 1978;1(6104):29-30
4. Maddox PR, Harrison BJ, Mansel RE, et al. Non-cyclical mastalgia: an improved classification and treatment. Br J Surg 1989;76(9):901-4
5. Parlati E, Travaglini A, Liberale I, et al. Hormonal profile in benign breast disease: endocrine status of cyclical mastalgia patients. J Endocrinol Invest 1988;11(9):679-83
6. Gateley CA, Maddox PR, Pritchard GA, et al. Plasma fatty acid profiles in benign breast disorders. Br J Surg 1992;79(5):407-9
7. Kumar S, Mansel RE, Wilson DW, et al. Daily salivary progesterone levels in cyclical mastalgia patients and their controls. Br J Surg 1986;73(4):260-3
8. Preece PE, Richards AR, Owen GM, et al. Mastalgia and total body water. Br Med J 1975;4(5995):498-500
9. Mansel RE. ABC of breast diseases: breast pain. BMJ 1994;309(6958):866-8
10. Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet 1985;2(8451):373-7
11. Smallwood JA, Kye DA, Taylor I. Mastalgia: is this commonly associated with operable breast cancer? Ann R Coll Surg Engl 1986;68(5):262-3
12. Fariselli G, Lepera P, Viganotti G, et al. Localized mastalgia as presenting symptom in breast cancer. Eur J Surg Oncol 1988; 14(3):213-5
13. Plu-Bureau G, Thalabard JC, Sitruk-Ware R, et al. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992;65(6):945-9
14. Moe R. Clinical approach to breast disease. In: Stenchever MA, ed. Office gynecology. St Louis: Mosby Year Book, 1992:236
15. Gateley CA, Miers M, Mansel RE, et al. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R Soc Med 1992;85(1):12-5
16. Smallwood J, Ah-Kye D, Taylor I. Vitamin B6 in the treatment of pre-menstrual mastalgia. Br J Clin Pract 1986;40(12):532-3
17. Maddox PR, Harrison BJ, Horobin JM, et al. A randomised controlled trial of medroxyprogesterone acetate in mastalgia. Ann R Coll Surg Engl 1990;72(2):71-6
18. Gateley CA, Maddox PR, Mansel RE, et al. Mastalgia refractory to drug treatment. Br J Surg 1990;77(10):1110-2
19. Holland PA, Gateley CA. Drug therapy of mastalgia: what are the options? Drugs 1994;48(5):709-16
20. Greenblatt RB, Dmowski WP, Mahesh VB, et al. Clinical studies with an anti-gonadotropin-danazol. Fertil Steril 1971; 22(2):102-12
21. Hinton CP, Bishop HM, Holliday HW, et al. A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 1986;40(8):326-30
22. Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1982;1(8278):928-30
23. Sutton GL, O'Malley VP. Treatment of cyclical mastalgia with low dose short-term danazol. Br J Clin Pract 1986;40(2): 68-70
24. Maddox PR, Harrison BJ, Mansel RE. Low-dose danazol for mastalgia. Br J Clin Pract Symp (Suppl) 1989;68:43-7; discussion 49-53
25. Nazli K, Syed S, Mahmood MR, et al. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia. Br J Clin Pract 1989;43(9):322-7
26. Mansel RE, Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 1990;335(8683):190-3
27. Mansel RE, Preece PE, Hughes LE. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg 1978;65(10):724-7
28. Fentiman IS, Caleffi M, Hamed H, et al. Studies of tamoxifen in women with mastalgia. Br J Clin Pract Symp (Suppl) 1989;68:34-6; discussion 49-53
29. Fentiman IS, Caleffi M, Hamed H, et al. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988;75(9):845-6
30. Fentiman IS. Tamoxifen and mastalgia: an emerging indication. Drugs 1986; 32(6):477-80
31. Cook LS, Weiss NS, Schwartz SM, et al. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer lnst 1995;87(18): 1359-64
32. Hamed H, Caleffi M, Chaudary MA, et al. LHRH analogue for treatment of recurrent and refractory mastalgia. Ann R Coll Surg Engl 1990;72(4):221-4
33. Roberts JV. Experience in the use of nafarelin for treatment of benign breast disease. Br J Clin Pract Symp (Suppl) 1989; 68:37-42; discussion 49-53
34. Peters F. Multicentre study of gestrinone in cyclical breast pain. Lancet 1992; 339(8787):205-8